FAPI-PET Scan for Esophageal Cancer Surgery Planning
Part of Cancer, Digestive system clinical trials.
This trial tests whether a special PET scan called FAPI-PET can better show the edges of esophageal tumors before surgery. It may help doctors plan more precise surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of adenocarcinoma or squamous cell carcinoma of the esophagus (including AEG I or II).
- Your treatment plan must include surgery to remove the tumor.
- You need to be generally well enough to care for yourself (ECOG 0/1 or Karnofsky index of 60% or more).
- You must be at least 18 years old.
- You cannot have had radiation to the tumor area before, nor have cancer that has spread to distant organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of PET scan called FAPI PET to see if it can help detect or monitor cancer and other diseases. It is for people who already need a PET or CT/MRI scan as part of their standard care.
This trial tests a new PET scan drug (18F-FAPI) to see if it can better detect where stomach or esophageal cancer has spread. It may help doctors plan the right treatment for you.
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
This trial uses a special PET/CT scan to see how well your esophageal cancer responds to chemotherapy and radiation. It helps doctors find out if the treatment is working early on.
This trial is testing a new imaging method called FAPI-PET to see if it can help find and understand tumors better than standard scans. It is for people with newly diagnosed stomach/esophageal cancer, pancreatic cancer, or those with unclear symptoms or scan results.
This trial uses two types of PET scans (18F-FDG and 18F-FAPI) to see if they can better predict how well chemotherapy works before surgery for stomach cancer. It aims to improve treatment planning and outcomes.
Hear when a new Esophagus Cancer, Stage I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.